Recent Finacing
Recent Raise
EndoQuest Robotics develops the ELS flexible endoluminal robotic surgical platform for minimally invasive gastrointestinal lesion treatment, conducting IDE‑approved PARADIGM clinical trials and operating U.S. and Korea campuses.
